[HTML][HTML] Molecular mechanisms for ketone body metabolism, signaling functions, and therapeutic potential in cancer

CY Hwang, W Choe, KS Yoon, J Ha, SS Kim, EJ Yeo… - Nutrients, 2022 - mdpi.com
The ketone bodies (KBs) β-hydroxybutyrate and acetoacetate are important alternative
energy sources for glucose during nutrient deprivation. KBs synthesized by hepatic …

Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways

K Feng, C Liu, W Wang, P Kong… - … Journal of Oncology, 2023 - spandidos-publications.com
Despite achieving optimal initial responses to androgen deprivation therapy, most patients
with prostate cancer eventually progress to a poor prognosis state known as castration …

Persistent organic pollutants promote aggressiveness in prostate cancer

J Buñay, M Kossai, C Damon-Soubeyrant, A De Haze… - Oncogene, 2023 - nature.com
Increasing evidence points towards a causal link between exposure to persistent organic
pollutants (POPs) with increased incidence and aggressivity of various cancers. Among …

Elevated serum β-hydroxybutyrate, a circulating ketone metabolite, accelerates colorectal cancer proliferation and metastasis via ACAT1

T Mao, F Qin, M Zhang, J Li, J Li, M Lai - Oncogene, 2023 - nature.com
Colorectal cancer (CRC) ranks third in incidence and second in mortality worldwide.
Metabolic disorders are known to be closely associated with CRC. Functional metabolomics …

[HTML][HTML] Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series

N Anselmino, E Labanca, PDA Shepherd, J Dong… - Clinical Cancer …, 2024 - AACR
Purpose: Develop and deploy a robust discovery platform that encompasses heterogeneity,
clinical annotation, and molecular characterization and overcomes the limited availability of …

Molecular heterogeneity in prostate cancer and the role of targeted therapy

S Khan, P Baligar, C Tandon, J Nayyar, S Tandon - Life Sciences, 2023 - Elsevier
Data collected from large-scale studies has shown that the incidence of prostate cancer
globally is on the rise, which could be attributed to an overall increase in lifespan. So, the …

siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway

Y Yu, D Papukashvili, R Ren, N Rcheulishvili… - Future …, 2023 - Taylor & Francis
Androgen deprivation therapy is a common treatment method for metastatic prostate cancer
through lowering androgen levels; however, this therapy frequently leads to the …

Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer

D Evin, A Evinová, E Baranovičová… - International Journal of …, 2024 - mdpi.com
Metastatic castration-resistant prostate cancer (mCRPC) remains a lethal disease due to the
absence of effective therapies. A more comprehensive understanding of molecular events …

[HTML][HTML] Bone progenitors pull the strings on the early metabolic rewiring occurring in prostate cancer cells

P Sanchis, N Anselmino, S Lage-Vickers, A Sabater… - Cancers, 2022 - mdpi.com
Simple Summary Almost 90% of prostate cancer metastases occur in bone. The arrival of
tumor cells to the homing organ requires a metabolic adaptation to different nutrients and …

[HTML][HTML] Emerging proteins in CRPC: functional roles and clinical implications

P Kong, L Zhang, Z Zhang, K Feng, Y Sang… - Frontiers in …, 2022 - frontiersin.org
Prostate cancer (PCa) is the most common cancer in men in the western world, but the lack
of specific and sensitive markers often leads to overtreatment of prostate cancer which …